期刊文献+

PCNA和MMP9在宫颈癌组织中的表达与意义 被引量:2

Expressions and significance of PCNA and MMP9 in cervix cancer tissue
下载PDF
导出
摘要 目的:探讨PCNA,MMP9在宫颈癌组织中的表达及临床意义.方法:用免疫组织化学SP法检测46例宫颈癌及10例正常宫颈中PCNA和MMP9的表达,分析不同组织中PCNA和MMP9表达的差异及两者的相关性.结果:宫颈癌组织PCNA的表达明显高于正常宫颈组织(P=0.000);38例宫颈癌的MMP9阳性表达(82.61%)明显高于10例正常宫颈组织的表达(30%,P<0.05);PCNA的表达与MMP9的表达呈正相关(rs=0.433,P=0.003),且PCNA和MMP9均与临床分期有关(P<0.05),而与年龄、病例分级及生长方式无关(P>0.05).结论:MMP9在宫颈癌组织中表达异常增高,与细胞增殖关系密切,提示其对宫颈癌的发展起重要作用. AIM: To investigate the expressions of PCNA and MMP9 in cervix cancer tissue and their significance. METHODS: The immunohistochemical SP staining method was used to evaluate the PCNA and MMP9 expressions in 46 cases of cervix cancer tissues and 10 cases of normal cervix tissues. RESULTS: The expression of PCNA in cervix cancer tissues was much higher than that in normal cervix tissues ( P = 0.000 ) ; The positive rate of MMP9 protein 82.61% in 46 cases of cervix cancer was significantly higher than that in 10 cases of normal cervix (30%, P 〈 0. 05 ). There was a positive correlation between PCNA and MMP9 expressions ( re = 0. 433, P = 0. 003 ). The expressions of PCNA and MMP9 were correlated with the clinical stage ( P 〈 0.05 ), but not with age, pathological stage or growth pattern ( P 〉 0.05 ). CONCLUSION : The over-expression of MMP9 has a close relationship with the cell proliferation index in cervix cancer, suggesting that MMP9 may play an important role in the development of cervix cancer.
出处 《第四军医大学学报》 CAS 北大核心 2006年第22期2060-2062,共3页 Journal of the Fourth Military Medical University
关键词 宫颈肿瘤 增殖细胞核抗原 明胶酶B 免疫组织化学 cervix neoplasms proliferating cell nuclear antigen (PCNA) gelatinase B immunohistochemistry
  • 相关文献

参考文献8

  • 1Fernandez-Sanchez M,Gamboa-Dominguez A,Uribe N,et al.Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer[J].Med Oncol,2006,23(2):171-183.
  • 2Rytkonen AK,Vaara M,Nethanel T,et al.Distinctive activities of DNA polymerases during human DNA replication[J].FEBS J,2006,273(13):2984-3001.
  • 3Nair A,Venkatraman M,Maliekal TT,et al.NFkβ is constitutively activated in high-grade squamous in traeoithelial lesions and squamous cell carcinomas of the huaman uterine cervix[J].Oncogene,2003,22(2):50-80.
  • 4牟晓燕,李怀臣,韩俊庆,黄琛,张维东.MMP_2和MMP_9在非小细胞肺癌组织中的表达[J].山东医药,2004,44(25):7-8. 被引量:8
  • 5Parkin DM.Global cancer statistics in the year 2000[J].Lancet Oncol,2001,2(9):533-543.
  • 6Taftachi R,Ayhan A,Ekici S,et al.Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomv:a comparison of PCNA and Ki-67[J].BJU Int,2005,95(4):650-654.
  • 7Morgan H,Hill PA.Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity[J].Cancer Cell Int,2005,5(1):1-5.
  • 8何茵芳,吴智玉,韩钦玮.卵巢上皮性癌PTEN和PCNA的表达[J].第四军医大学学报,2005,26(19):1808-1810. 被引量:6

二级参考文献9

  • 1Maeta H,Ohgi S,Terada T,et al.Protein expression of matrix metallopro-teinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.Virchows Arch,2001,438(2):121~128.
  • 2Nakamura H,Ueno H,Yamashita K,et al.Enhanced production andactivation of progelatinase A mediated by membrane type Ⅰmatrixmetalloproteinase in human papillary thyroid carcinomas.Cancer Res,1999,59(2):467~473.
  • 3Hirai Y, Tanaka N, Furuta R,et al. Somatic mutations of the PTEN/MMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer[J]. Gynecol Oncol, 2001;83(1):81-88.
  • 4Nakako S, Hajime T, Masato N. Loss of heterozygosity on 10q 23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: Possible sequence progression from benign endometrial cyst to endometrial carcinoma and clear cell carcinoma of ovary[J]. Cancer Res, 2000;60(18):7052-7056.
  • 5Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer[J]. Science, 1997;275(8):1943-1949.
  • 6Steck PA, Pershouse MA, Jasser SA,et al. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancer[J]. Nat Genet, 1997;15(2):356-362.
  • 7Li DM, Sun H. Encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factorβ[J]. Cancer Res,1997;57(9):2124-2130.
  • 8Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinoma[J]. Am J Pathol, 2001;158(9):2097-2106.
  • 9李红梅,方伟岗,郑杰,张骏,由江峰,吴秉铨.不同转移潜能的人肿瘤细胞系金属蛋白酶活性分析[J].中华病理学杂志,1998,27(5):341-343. 被引量:47

共引文献12

同被引文献23

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部